Abstract
To determine the risk for recurrence of venous thromboembolic disease is essential to decide the optimum duration of treatment. Clinical risk factors, elevated D-dimer after anticoagulation withdrawal and the presence of residual deep vein thrombosis should be considered. In this article the risk factors and the reported risk models are reviewed.
Copyright © 2012 Elsevier España, S.L. All rights reserved.
MeSH terms
-
Anticoagulants / therapeutic use*
-
Biomarkers / blood
-
Decision Support Techniques*
-
Humans
-
Practice Guidelines as Topic
-
Pulmonary Embolism / blood
-
Pulmonary Embolism / etiology
-
Pulmonary Embolism / prevention & control*
-
Risk Assessment
-
Risk Factors
-
Secondary Prevention
-
Venous Thromboembolism / blood
-
Venous Thromboembolism / etiology
-
Venous Thromboembolism / prevention & control*
-
Venous Thrombosis / blood
-
Venous Thrombosis / etiology
-
Venous Thrombosis / prevention & control*
-
Withholding Treatment*
Substances
-
Anticoagulants
-
Biomarkers